Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Sales | 7,092 | 6,554 | 7,313 | 3,836 | 534 |
| Cost of Goods | 0 | 0 | 0 | 0 | 3,136 |
| Gross Profit | 7,092 | 6,554 | 7,313 | -2,450 | -2,603 |
| Operating Expenses | 49,395 | 29,913 | 16,887 | 2,018 | 1,196 |
| Operating Income | -42,302 | -23,359 | -9,574 | 1,819 | -3,662 |
| Interest Expense | 1,046 | 736 | 89 | 10 | 23 |
| Other Income | 3,464 | 4,982 | 5,195 | -5,107 | 1,029 |
| Pre-tax Income | -39,884 | -19,113 | -4,468 | -3,298 | -2,656 |
| Net Income Continuous | -39,884 | -19,113 | -4,468 | -3,298 | -2,656 |
| Net Income | $-39,884 | $-19,113 | $-4,468 | $-3,298 | $-2,656 |
| EPS Basic Total Ops | -2.41 | -1.24 | -0.35 | -0.63 | -0.55 |
| EPS Basic Continuous Ops | -2.12 | -1.25 | -0.29 | -0.63 | -0.55 |
| EPS Diluted Total Ops | -2.41 | -1.25 | -0.29 | -0.63 | -0.55 |
| EPS Diluted Continuous Ops | -2.12 | -1.25 | -0.29 | -0.63 | -0.55 |
| EBITDA(a) | $-39,201 | $-21,249 | $-8,795 | $2,143 | $-3,469 |